Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

White House taps Inglesby as COVID testing coordinator

Published 01/12/2022, 09:38 AM
Updated 01/12/2022, 09:41 AM
© Reuters. FILE PHOTO: A man is tested for coronavirus disease (COVID-19) at the Tower Theatre in Oklahoma City, Oklahoma, U.S., January 11, 2022.  REUTERS/Nick Oxford
TWTR
-

WASHINGTON (Reuters) - The White House has tapped Dr. Tom Inglesby, the former director of Johns Hopkins Center for Health Security, to lead the government's COVID-19 testing initiative, press secretary Jen Psaki said on Tuesday.

The appointment, confirmed by Psaki in a Twitter (NYSE:TWTR) post, comes as the federal government seeks to ramp up testing amid the fast-spreading Omicron variant.

"Dr. Inglesby is one of the world’s leading infectious disease experts and is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats," a White House official told Reuters.

The United States reported 1.35 million new coronavirus infections on Monday https://www.reuters.com/business/healthcare-pharmaceuticals/us-reports-least-11-mln-covid-cases-day-shattering-global-record-2022-01-11, shattering the global record for daily cases in any one country. Omicron is now estimated to account for 98.3% of total new cases circulating in the country, the Centers for Disease Control and Prevention (CDC) says.

© Reuters. FILE PHOTO: A man is tested for coronavirus disease (COVID-19) at the Tower Theatre in Oklahoma City, Oklahoma, U.S., January 11, 2022.  REUTERS/Nick Oxford

Critics have accused President Joe Biden of not focusing enough on testing in the fight to control surging Omicron cases and hospitalizations, amid growing reports of acute shortages of test kits around the country.

The White House and top health officials have defended the response, including announcing this month that 500 million rapid tests would be available free to all Americans in January.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.